Literature DB >> 12723281

WHO recommended measures for persons undertaking international travel from areas affected by severe acute respiratory syndrome (SARS).

.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12723281

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  16 in total

Review 1.  SARS coronavirus: a new challenge for prevention and therapy.

Authors:  Kathryn V Holmes
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

2.  [SARS: solution by actions and responses with sense].

Authors:  José María Martín-Moreno
Journal:  Med Clin (Barc)       Date:  2004-11-13       Impact factor: 1.725

3. 

Authors:  Francisco Ríos Tejada
Journal:  FMC       Date:  2009-01-06

Review 4.  [Air travel and respiratory diseases].

Authors:  Francisco García Río; Luis Borderías Clau; Ciro Casanova Macario; Bartolomé R Celli; Joan Escarrabill Sanglás; Nicolás González Mangado; Josep Roca Torrent; Fernando Uresandi Romero
Journal:  Arch Bronconeumol       Date:  2007-02       Impact factor: 4.872

5.  The Ashwell receptor mitigates the lethal coagulopathy of sepsis.

Authors:  Prabhjit K Grewal; Satoshi Uchiyama; David Ditto; Nissi Varki; Dzung T Le; Victor Nizet; Jamey D Marth
Journal:  Nat Med       Date:  2008-05-18       Impact factor: 53.440

6.  Cross-sectional study of nasopharyngeal carriage of Streptococcus pneumoniae in human immunodeficiency virus-infected adults in the conjugate vaccine era.

Authors:  Chinwendu Onwubiko; Edwin Swiatlo; Larry S McDaniel
Journal:  J Clin Microbiol       Date:  2008-09-24       Impact factor: 5.948

7.  Evaluation of WHO criteria for identifying patients with severe acute respiratory syndrome out of hospital: prospective observational study.

Authors:  Timothy H Rainer; Peter A Cameron; DeVilliers Smit; Kim L Ong; Alex Ng Wing Hung; David Chan Po Nin; Anil T Ahuja; Louis Chan Yik Si; Joseph J Y Sung
Journal:  BMJ       Date:  2003-06-21

8.  S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients.

Authors:  Heike Hofmann; Kim Hattermann; Andrea Marzi; Thomas Gramberg; Martina Geier; Mandy Krumbiegel; Seraphin Kuate; Klaus Uberla; Matthias Niedrig; Stefan Pöhlmann
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  SARS-CoV 9b protein diffuses into nucleus, undergoes active Crm1 mediated nucleocytoplasmic export and triggers apoptosis when retained in the nucleus.

Authors:  Kulbhushan Sharma; Sara Åkerström; Anuj Kumar Sharma; Vincent T K Chow; Shumein Teow; Bernard Abrenica; Stephanie A Booth; Timothy F Booth; Ali Mirazimi; Sunil K Lal
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

10.  Introduction of SARS in France, March-April, 2003.

Authors:  Jean-Claude Desenclos; Sylvie van der Werf; Isabelle Bonmarin; Daniel Levy-Bruhl; Yazdan Yazdanpanah; Bruno Hoen; Julien Emmanuelli; Olivier Lesens; Michel Dupon; François Natali; Christian Michelet; Jacques Reynes; Benoit Guery; Christine Larsen; Caroline Semaille; Daniel Mouton; Michel André; Nicolas Escriou; Anna Burguière; Jean-Claude Manuguerra; Bruno Coignard; Agnés Lepoutre; Christine Meffre; Dounia Bitar; Bénédicte Decludt; Isabelle Capek; Denise Antona; Didier Che; Magid Herida; Andréa Infuso; Christine Sauri; Gilles Brücker; Bruno Hubert; Dominique LeGoff; Suzanne Scheidegger
Journal:  Emerg Infect Dis       Date:  2004-02       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.